Published in Mol Cell Biol on November 01, 1997
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A (2000) 3.36
Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol (2004) 2.56
O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem (2008) 2.27
Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab (2006) 2.12
Two O-linked N-acetylglucosamine transferase genes of Arabidopsis thaliana L. Heynh. have overlapping functions necessary for gamete and seed development. Genetics (2002) 1.72
Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem (2008) 1.62
Chemical approaches to understanding O-GlcNAc glycosylation in the brain. Nat Chem Biol (2008) 1.60
O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci U S A (2001) 1.60
Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta (2010) 1.55
Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. Proc Natl Acad Sci U S A (2000) 1.39
Glucose mediates the translocation of NeuroD1 by O-linked glycosylation. J Biol Chem (2007) 1.25
Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J (2007) 1.22
O-GlcNAc cycling: implications for neurodegenerative disorders. Int J Biochem Cell Biol (2009) 1.22
An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate. J Virol (2005) 1.19
Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway rats. Biogerontology (2008) 1.12
Two transcription factors are negative regulators of gibberellin response in the HvSPY-signaling pathway in barley aleurone. Plant Physiol (2004) 1.11
The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem J (2001) 1.04
O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter. J Virol (2009) 1.03
Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem J (2000) 1.02
Molecular mechanisms of diabetic vascular complications. J Diabetes Investig (2010) 1.01
Sp1 is essential for p16 expression in human diploid fibroblasts during senescence. PLoS One (2007) 1.00
Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes. Mol Cell Endocrinol (2009) 0.96
Phosphorylation of transcription factor Sp1 during herpes simplex virus type 1 infection. J Virol (2002) 0.96
The specificity protein factor Sp1 mediates transcriptional regulation of P2X7 receptors in the nervous system. J Biol Chem (2012) 0.91
Hyperglycemia mediates a shift from cap-dependent to cap-independent translation via a 4E-BP1-dependent mechanism. Diabetes (2013) 0.88
Post-translational control of sp-family transcription factors. Curr Genomics (2008) 0.85
Distinct OGT-Binding Sites Promote HCF-1 Cleavage. PLoS One (2015) 0.84
O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells. Invest Ophthalmol Vis Sci (2014) 0.83
Regulation of the ClC-2 lung epithelial chloride channel by glycosylation of SP1. Am J Respir Cell Mol Biol (2006) 0.83
O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells. PLoS One (2013) 0.82
Arabidopsis ROCK1 transports UDP-GlcNAc/UDP-GalNAc and regulates ER protein quality control and cytokinin activity. Proc Natl Acad Sci U S A (2014) 0.82
Global O-GlcNAc Levels Modulate Transcription of the Adipocyte Secretome during Chronic Insulin Resistance. Front Endocrinol (Lausanne) (2015) 0.82
Hsp90 regulates O-linked β-N-acetylglucosamine transferase: a novel mechanism of modulation of protein O-linked β-N-acetylglucosamine modification in endothelial cells. Am J Physiol Cell Physiol (2012) 0.81
Suppressive regulation of KSHV RTA with O-GlcNAcylation. J Biomed Sci (2012) 0.80
Hexosamine biosynthesis impairs insulin action via a cholesterolgenic response. Mol Endocrinol (2013) 0.80
Specificity protein 1 regulates gene expression related to fatty acid metabolism in goat mammary epithelial cells. Int J Mol Sci (2015) 0.80
Protein multifunctionality: principles and mechanisms. Transl Oncogenomics (2008) 0.78
The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression. Curr Signal Transduct Ther (2010) 0.76
Identification of the nuclear localisation signal of O-GlcNAc transferase and its nuclear import regulation. Sci Rep (2016) 0.75
Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell (1988) 12.68
The ubiquitin-proteasome proteolytic pathway. Cell (1994) 9.75
Negative effect of the transcriptional activator GAL4. Nature (1988) 7.15
Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell (1993) 5.91
O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell (1988) 5.82
Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem (1984) 5.14
Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell (1993) 4.57
Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev (1991) 4.54
Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell (1989) 4.49
A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc Natl Acad Sci U S A (1994) 4.27
Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev (1991) 4.23
GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell (1990) 4.04
DNA template and activator-coactivator requirements for transcriptional synergism by Drosophila bicoid. Science (1995) 3.79
Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. Genes Dev (1991) 3.77
Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J Cell Biol (1987) 3.73
The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol Chem (1986) 3.66
Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science (1988) 3.23
Vaccinia virus: a tool for research and vaccine development. Science (1991) 3.21
Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J Biol Chem (1994) 2.73
Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem (1997) 2.69
RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J Biol Chem (1993) 2.68
c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem (1995) 2.47
Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol (1997) 2.45
The cAMP-regulated transcription factor CREB interacts with a component of the TFIID complex. Proc Natl Acad Sci U S A (1994) 1.95
Glycosylation in the nucleus and cytoplasm. Annu Rev Biochem (1989) 1.87
Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. J Biol Chem (1992) 1.82
Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc Natl Acad Sci U S A (1991) 1.60
Retracted TAF(II)s mediate activation of transcription in the Drosophila embryo. Cell (1996) 1.39
A nuclear specific glycoprotein representative of a unique pattern of glycosylation. J Biol Chem (1987) 1.34
Localization of O-GlcNAc modification on the serum response transcription factor. J Biol Chem (1992) 1.27
Glycosylation of nuclear pore protein p62. Reticulocyte lysate catalyzes O-linked N-acetylglucosamine addition in vitro. J Biol Chem (1990) 1.08
Identification and characterization of the human transforming growth factor-alpha initiator. Mol Endocrinol (1994) 0.82
Gas-bubble lesions in stranded cetaceans. Nature (2003) 5.95
Transport of live animals for slaughter. Vet Rec (1991) 3.83
Hypersensitivity reactions from taxol. J Clin Oncol (1990) 3.83
Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta (1983) 3.29
The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. Proc Natl Acad Sci U S A (1996) 2.85
The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo. Magn Reson Med (1995) 2.59
Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. J Biol Chem (1983) 2.50
Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol (1997) 2.45
Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A (1996) 2.39
Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc (1985) 2.27
Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science (1991) 2.11
The 'Ryan virus'. Parasitol Today (1989) 2.02
Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J (Clin Res Ed) (1983) 2.01
The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol (1996) 1.82
The nuclear hormone receptor Ftz-F1 is a cofactor for the Drosophila homeodomain protein Ftz. Nature (1997) 1.82
Heteroplasmic point mutations in the human mtDNA control region. Am J Hum Genet (1996) 1.78
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
Imaging subcortical auditory activity in humans. Hum Brain Mapp (1998) 1.74
Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature (1984) 1.69
Variation in the degree of synchronization exhibited by motor units lying in different finger muscles in man. J Physiol (1991) 1.62
O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci U S A (2001) 1.60
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol (1988) 1.59
The primary structure of link protein from rat chondrosarcoma proteoglycan aggregate. J Biol Chem (1986) 1.56
HLA antigen contamination of commercial Western blot strips for detecting human immunodeficiency virus. J Infect Dis (1989) 1.52
Correlation between the discharges of motor units recorded from the same and from different finger muscles in man. J Physiol (1991) 1.52
Endothelium-dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalim. Br J Pharmacol (1988) 1.51
A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. J Infect Dis (1999) 1.51
Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF. Proc Natl Acad Sci U S A (1982) 1.47
Bleomycin-induced interstitial pneumonia in dogs. Thorax (1971) 1.47
The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J Biol Chem (1996) 1.47
Isolation and characterization of the chains of type V/type XI collagen present in bovine vitreous. J Biol Chem (1993) 1.46
Immunological determinants of proteoglycans. Antibodies against the unsaturated oligosaccharide products of chondroitinase ABC-digested cartilage proteoglycans. J Biol Chem (1980) 1.45
A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol Res (2001) 1.44
Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol (1997) 1.42
Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ (1995) 1.41
Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. Proc Natl Acad Sci U S A (2000) 1.39
Diffuse alveolar damage in the horse. Equine Vet J (1995) 1.39
Enhanced two-photon biosensing with double-clad photonic crystal fibers. Opt Lett (2003) 1.37
Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A (1992) 1.37
Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice. Oncogene (1999) 1.35
Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription. J Biol Chem (1996) 1.34
Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res (1996) 1.32
Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5. Cancer Res (1998) 1.29
Cloning and expression of the gene for group B streptococcal hyaluronate lyase. J Biol Chem (1994) 1.29
Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. Biomaterials (2000) 1.26
Cytotoxicity of antibody-coated trypanosomes by normal human lymphoid cells. Nature (1976) 1.25
The isolation and characterization of the link proteins from proteoglycan aggregates of bovine nasal cartilage. J Biol Chem (1979) 1.25
Immune mechanisms in Graves' disease. Endocr Rev (1985) 1.25
Biosynthesis of chondroitin sulfate proteoglycan. Xylosyl transfer to Smith-degraded cartilage proteoglycan and other exogenous acceptors. J Biol Chem (1972) 1.24
A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study. Diabetologia (2009) 1.22
Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins. Proc Assoc Am Physicians (1999) 1.22
Monoclonal antibodies as probes for determining the microheterogeneity of the link proteins of cartilage proteoglycan. J Biol Chem (1985) 1.21
Deformability of poly(amidoamine) dendrimers. Eur Phys J E Soft Matter (2004) 1.21
Cartilage proteoglycan aggregates. The link protein and proteoglycan amino-terminal globular domains have similar structures. J Biol Chem (1987) 1.20
Glucose regulation of transforming growth factor-alpha expression is mediated by products of the hexosamine biosynthesis pathway. Mol Endocrinol (1993) 1.19
Salmonellosis in the horse. Br Vet J (1970) 1.19
Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol (1993) 1.16
Significant DQw1 association in achalasia. Dig Dis Sci (1989) 1.16
Anti-pp60src antibodies are substrates for EGF-stimulated protein kinase. Nature (1981) 1.16
Antimicrobial mechanism of action of surfactant lipid preparations in enteric Gram-negative bacilli. J Appl Microbiol (2000) 1.15
Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers. Bioconjug Chem (1999) 1.15
Characterization of the group B streptococcal hyaluronate lyase. Arch Biochem Biophys (1994) 1.15
The link proteins as specific components of cartilage proteoglycan aggregates in vivo. Associative extraction of proteoglycan aggregate from swarm rat chondrosarcoma. J Biol Chem (1979) 1.15
A light microscopical study of healing incised dermal wounds in rats, with special reference to eosinophil leucocytes and to the collagenous fibres of the periwound areas. Br J Exp Pathol (1977) 1.14
Comparison of collagenase activity in eosinophil and neutrophil fractions from rat peritoneal exudates. Aust J Exp Biol Med Sci (1976) 1.12
Epidermal growth factor stimulates the synthesis of its own receptor in a human breast cancer cell line. J Biol Chem (1986) 1.12
An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J Biol Chem (1999) 1.11
Lesions of the nasal and paranasal sinuses of the horse causing dyspnoea. Br Vet J (1975) 1.11
Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus. Br Med J (Clin Res Ed) (1985) 1.10
Effect of task on the degree of synchronization of intrinsic hand muscle motor units in man. J Neurophysiol (1991) 1.09
Neonatal diarrhoea in calves. Vet Rec (1974) 1.09
Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem (1985) 1.08
Radioimmunoassay of the link proteins associated with bovine nasal cartilage proteoglycan. J Biol Chem (1979) 1.08
Control of macromolecular synthesis in proliferating and resting Syrian hamster cells in monolayer culture. II. Ribosome complement in resting and early G1 cells. J Cell Physiol (1971) 1.07
The immune response to papillary thyroid cancer. J Clin Endocrinol Metab (1995) 1.06
Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-alpha in a breast cancer cell line. J Biol Chem (1989) 1.06
Phosphorylation of human glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase at serine 205 blocks the enzyme activity. J Biol Chem (2000) 1.06
Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg (1985) 1.06
Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles. Cell Growth Differ (1998) 1.05
Alpha-transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture. II. Identification using a sequence-specific monoclonal antibody. J Biol Chem (1986) 1.05
The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. Biochim Biophys Acta (1997) 1.04
The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem J (2001) 1.04
Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management. Br Med J (Clin Res Ed) (1984) 1.02
Inactivation of Ebola virus with a surfactant nanoemulsion. Acta Trop (2003) 1.02
Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem J (2000) 1.02
An amino acid sequence common to both cartilage proteoglycan and link protein. J Biol Chem (1985) 1.02
Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem (1996) 1.01
Electron microscope studies on motile stages of malaria parasites. VI. The oökinete of Plasmodium berghei yoelii and its transformation into the early oöcyst. Trans R Soc Trop Med Hyg (1969) 1.01
Central neuropeptide B administration activates stress hormone secretion and stimulates feeding in male rats. J Neuroendocrinol (2004) 1.01
Cloning and characterization of a novel human DNase. Biochem Biophys Res Commun (1997) 1.01
Cloning and characterization of a novel human chemokine receptor. Biochem Biophys Res Commun (1998) 1.01
Aorto-cardiac fistulas in seven horses. Vet Radiol Ultrasound (1998) 1.01
A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region. Genomics (2000) 1.01
Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus. Genomics (2001) 1.01
The C1q inhibitor in serum is a chondroitin 4-sulfate proteoglycan. J Biol Chem (1981) 1.00
A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. Genomics (1997) 1.00